Vanguard Personalized Indexing Management
CHRS icon

Vanguard Personalized Indexing Management’s Coherus Oncology CHRS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.4K Sell
33,150
-256
-0.8% -$418 ﹤0.01% 2147
2026
Q1 		$56.5K Sell
33,406
-1,432
-4% -$2.54K ﹤0.01% 2036
2025
Q4 		$49.5K Buy
34,838
+373
+1% +$544 ﹤0.01% 1883
2025
Q3 		$56.5K Buy
34,465
+3,694
+12% +$4.11K ﹤0.01% 1891
2025
Q2 		$22.5K Buy
30,771
+2,673
+10% +$2.31K ﹤0.01% 1898
2025
Q1 		$22.7K Sell
28,098
-5,130
-15% -$5.9K ﹤0.01% 1759
2024
Q4 		$45.9K Buy
+33,228
New +$37.3K ﹤0.01% 1704

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Vanguard Personalized Indexing Management's CHRS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Coherus Oncology (CHRS) stake by 0.77% in Q2 2026, selling an estimated $418 and leaving 33,150 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2147.

Vanguard Personalized Indexing Management first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. The position peaked at $56.5K in Q3 2025. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Vanguard Personalized Indexing Management held 33,150 shares of Coherus Oncology worth $46.4K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 256 Coherus Oncology shares in Q2 2026, an estimated $418.
  • Coherus Oncology made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2147 holding.
  • Vanguard Personalized Indexing Management first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
  • Vanguard Personalized Indexing Management's Coherus Oncology position peaked at $56.5K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.